Lantheus Holdings, Inc. Income Taxes Paid
Lantheus Holdings, Inc. (LNTH) reported Income Taxes Paid of $69.04 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-02-26
- Lantheus Holdings, Inc. income taxes paid, net for the quarter ending 2016-06-30 was $74.00K, a 43.94% decline year-over-year.
- Lantheus Holdings, Inc. income taxes paid, net for the quarter ending 2016-03-31 was $199.00K.
- Lantheus Holdings, Inc. income taxes paid, net for the quarter ending 2015-12-31 was $93.00K, a 30.08% decline year-over-year.
- Lantheus Holdings, Inc. income taxes paid, net for the quarter ending 2015-09-30 was $8.00K.
- Lantheus Holdings, Inc. income taxes paid, net for fiscal 2025 was $69.04M, a 55.12% decline from fiscal 2024.
- Lantheus Holdings, Inc. income taxes paid, net for fiscal 2024 was $153.81M, a 1.48% increase from fiscal 2023.
- Lantheus Holdings, Inc. income taxes paid, net for fiscal 2023 was $151.58M, a 180.45% increase from fiscal 2022.
- Lantheus Holdings, Inc. income taxes paid, net for fiscal 2022 was $54.05M, a 25039.07% increase from fiscal 2021.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2025-12-31 | $69.04M 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $153.81M 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $151.58M 10-K · filed 2026-02-26 | |||
| 2022-12-31 | $54.05M 10-K · filed 2025-02-26 | |||
| 2021-12-31 | $215.00K 10-K · filed 2024-02-22 | |||
| 2020-12-31 | $340.00K 10-K · filed 2023-02-23 | |||
| 2019-12-31 | $274.00K 10-K · filed 2022-02-24 | |||
| 2018-12-31 | $90.00K 10-K · filed 2021-02-25 | |||
| 2017-12-31 | $106.00K 10-K · filed 2020-02-25 | |||
| 2016-12-31 | $265.00K 10-K · filed 2019-02-20 | |||
| 2016-06-30 | $74.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $273.00K 10-Q · filed 2016-08-04 | $366.00K derived: sum of 3 quarters · filed 2018-02-26 | $374.00K derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $199.00K 10-Q · filed 2016-05-03 | $292.00K derived: sum of 2 quarters · filed 2018-02-26 | $300.00K derived: sum of 3 quarters · filed 2018-02-26 | $432.00K derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $101.00K derived: sum of 2 quarters · filed 2018-02-26 | $233.00K derived: sum of 3 quarters · filed 2018-02-26 | $174.00K 10-K · filed 2018-02-26 |
| 2015-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $140.00K derived: sum of 2 quarters · filed 2016-08-04 | $81.00K 10-Q · filed 2015-11-04 | $214.00K derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $132.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $73.00K 10-Q · filed 2016-08-04 | $206.00K derived: sum of 3 quarters · filed 2017-02-23 | $177.00K derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | -$59.00K 10-Q · filed 2016-05-03 | $74.00K derived: sum of 2 quarters · filed 2017-02-23 | $45.00K derived: sum of 3 quarters · filed 2017-02-23 | |
| 2014-12-31 | $133.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $104.00K derived: sum of 2 quarters · filed 2017-02-23 | $508.00K 10-K · filed 2017-02-23 | |
| 2014-09-30 | -$29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $375.00K 10-Q · filed 2015-11-04 | ||
| 2014-06-30 | $404.00K 10-Q · filed 2015-08-05 | |||
| 2013-12-31 | $118.00K 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |